Special issue: “Synthesis, Analysis and Applications of Cyclodextrins and Their Derivatives”
Molecules (mdpi) invites the submission of original research papers and review articles concerning innovative synthetic pathways for new CD derivatives,
New book: Natural Antioxidants to Enhance the Shelf-Life of Food
Natural Antioxidants to Enhance the Shelf-Life of Food, Volume Two in the Developments in Food Quality and Safety series is the most up-to-date
Meloxicam potassium containing nasal powders based on charged β-cyclodextrin
Nasal drug delivery is increasingly recognized as an alternative to oral and parenteral administration, offering advantages such as rapid absorption
Ipecon®: a novel betadex sulfobutylether sodium containing veterinary drug composition
A Russian startup company, Vetstem, located at Skolkovo, Moscow successfully markets an antiviral composition for the treatment of feline infectious
Rutin/Sulfobutylether-β-Cyclodextrin as a Promising Therapeutic Formulation for Ocular Infection
Ocular pathologies present significant challenges to achieving effective therapeutic results due to various anatomical and physiological barriers. Natural products such
US. Department of Agriculture: β-Cyclodextrin/carvacrol inclusion complex improves postharvest quality of limes
US. Department of Agriculture (USDA) has a vast public searchable database of scientific results financed by the Department. It has
Cyclodextrin Market Size & Forecast, 2024-2032
Acccording to the latest market analysis, Cyclodextrin Market size was valued at USD 289.3 million in 2023 and is projected
New methods of modification of α-cyclodextrin
While being some of the oldest supramolecular hosts, cyclodextrins remain very popular as molecular binders in materials, devices, artificial enzymes
A Novel In Situ Gelling System of Quercetin/Sulfobutyl-Ether-β-Cyclodextrin Complex-Loaded Chitosan Nanoparticles for the Treatment of Vulvovaginitis
Vulvovaginitis is a growing concern worldwide because of increasing drug resistance, drug toxicity, low bioavailability, and limitations of topical administration.
Rafael Holdings and Cyclo Therapeutics merge to advance Niemann-Pick drug as FDA rival decision nears
Rafael Holdings and Cyclo Therapeutics on Thursday announced a merger agreement as they look to spur development of their Niemann-Pick
Alpha-amylase sensor based on curcumin/HPBCD complex
Owing to the importance of α-amylase in industry, it is necessary to develop a more simple and practical approach to